Platelet and Plasma Market Size & Share 2020 to 2026

Market Size by Component (Platelets, Plasma), by Application (Hemophilia, Thrombocytopenia, Perioperative Indications, Platelet Function Disorders, Coagulation Factor Deficiencies, Thrombotic Thrombocytopenic Purpura, Hemorrhage, Liver Disease), by Distribution Channel (Hospitals, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Application Potential, Growth Potential, Price Trend, Competitive Market Share & Forecast.
Report ID: GMI2737
   |
Published Date: June 2020
 | 
Report Format: PDF

Download Free PDF

Platelet and Plasma Market Size

Platelet and Plasma Market size was more than USD 6.1 billion in 2019 and will witness 2.2% CAGR during 2020 to 2026. Platelet and plasma are critical parts of the treatment for several serious health problems. Platelets are tiny cell components of blood that helps in formation of blood clot to stop bleeding while plasma is a liquid component of blood that takes hormones, nutrients, and proteins to the different parts of body.
 

Platelet and Plasma Market

Increasing demand of platelet and plasma for the treatment of life-threatening diseases and deficiencies such as hemophilia, thrombocytopenia, coagulation factor deficiencies, liver disease along with other blood disorders will upsurge the industry growth. Favourable reimbursement policies in developed countries will further boost market demand over the projected timeline.
 

 

Platelet and Plasma Market Analysis

Increasing demand for blood transfusion procedures in Europe will propel the market growth over the forecast period. Recent years have seen an upsurge in number of blood banks in European countries to full fill the growing demand for platelet and plasma that stimulates the market growth. Blood transfusion in these countries is often a part of specialized healthcare system. For instance, in Norwegian hospitals there are currently more than 60 blood banks that provide all blood components including platelet and plasma. Numerous blood donations occur at accredited and certified blood banks. This will drive the market growth over the projected timeline.
 

Also, according to the World Health Organization (WHO), every year more than 115 million units of donated blood are collected worldwide and around 42% of these are collected in high-income nations of America and Europe. Increasing number of blood donation camps will significantly propel the market demand over forecast period.
 

Platelet and Plasma Market Size

The platelet market accounted for nearly USD 4.1 billion value in 2019, owing to the growing number of trauma cases and road accidents. Platelets play a critical role during surgeries and help in formation of blood clots to prevent excess bleeding.
 

Use of platelets and its derivatives for quick healing in various surgical procedures such as cardiothoracic surgery, maxillofacial diseases, and other musculoskeletal diseases is increasing globally. They are also used prominently in various orthopedic treatments such as total knee arthroplasty, osteoarthritis of shoulder, bone and ligament regeneration as well as soft tissue healing. This is anticipated to drive the segmental growth.
 

Hemophilia segment accounted for around 5.5% market share in 2019 and will witness significant market growth over the forecast period. The growth is attributed to increasing number of traumatic injuries leading to hemorrhage and imbalance of body hemostatic mechanism. Such factors will increase demand for blood transfusion leading to segmental growth. Hemophilia is more prevalent in patients with history of easy bleeding and bruising followed by surgery and is genetically transferred from one generation to another that will further augment the market growth.
 

Platelet & Plasma Market Share

Hospitals accounted for around 62% market share in 2019 and is estimated to grow significantly over the coming years. The growth of this segment is attributed to the higher availability of blood components such as platelet and plasma in hospitals, thus boosting the segmental growth.
 

The growth of the segment is also attributed to the growing number of surgeries that require blood transfusion. These procedures are mostly performed in hospital settings, thereby fostering the segment growth. Additionally, increasing number of well-established hospitals coupled with rising healthcare coverage is a positive impact rendering factor for the market growth.
 

North America platelet and plasma market is anticipated to hold a significant market share in 2019 and will witness over 1.5% CAGR during the analysis period. Regional growth is primarily attributed to favorable regulations pertaining to use of platelet and plasma derived products. Also, increasing number of patients suffering from obesity, cancer, cardiothoracic disorders as well as growing incidences of neurological conditions will increase the demand for platelet and plasma, thereby propelling the regional market growth.
 

Moreover, rising healthcare expenditure and various initiatives by organizations such as setting-up blood donation campaigns will further boost the regional market growth.
 

Platelet and Plasma Market Share

Some of the eminent industry participants operating in the platelet & plasma market share include:

  • America’s Blood Centers
  • American Association of Blood Banks
  • Blood Centers of America
  • Indian Red Cross
  • European Blood Alliance
  • Japanese Red Cross
  • Italian Red Cross
  • OneBlood
  • South African Red Cross Society
  • American Red Cross.

The notable market participants are strategically implementing several business strategies to increase the awareness among people pertaining to blood donation in order to meet the demand for platelet and plasma.
 

Some of the recent industry developments:

  • In April 2020, in the wake of COVID-19 pandemic, OneBlood, a not-for-profit blood center, initiated the collection of platelet and plasma from recovered patients of coronavirus. The collected plasma is transfused into the COVID-19 affected patients that aids them in recovery. The company’s active participation will serve for its growth in the industry.
     
  • In April 2018, American Red Cross relaunched the redesigned RedCrossBlood.org. This approach helped the donors to make donations more conveniently through improved content search, advanced personalization, and user-friendly interface. The launch was aimed to attract more donors that provided boost to the industry.
     

The platelet and plasma industry research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2015 to 2026, for the following segments:

By Component, 2015 – 2026 (USD Million)

  • Platelets
  • Plasma

By Application, 2015 – 2026 (USD Million)

  • Hemophilia
  • Thrombocytopenia
  • Perioperative indications
  • Platelet function disorders
  • Other platelet applications
  • Coagulation factor deficiencies
  • Thrombotic thrombocytopenic purpura
  • Hemorrhage
  • Liver disease
  • Other plasma applications

By Distribution Channel, 2015 – 2026 (USD Million)

  • Hospitals
  • Ambulatory surgical centers
  • Others

The above information is provided for the following geographies:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico 
  • Middle East
    • South Africa
    • Saudi Arabia
       

 

Authors: Monali Tayade, Jignesh Rawal
Platelet and Plasma Market Scope
  • Platelet and Plasma Market Size
  • Platelet and Plasma Market Trends
  • Platelet and Plasma Market Analysis
  • Platelet and Plasma Market Share

Report Content

Chapter 1.  Methodology

1.1. Methodology

1.2. Market definitions

1.3. Forecast parameters    

1.4. Data Sources

1.4.1.  Secondary

1.4.1.1.  Paid sources

1.4.1.2.    Unpaid sources

1.4.2.  Primary

Chapter 2.  Executive Summary

2.1. Platelet and plasma industry 3600 synopsis, 2015 – 2026

2.1.1.  Business trends

2.1.2.  Component trends

2.1.3.  Application trends

2.1.4.  Distribution channel trends

2.1.5.  Regional trends

Chapter 3.  Platelet and Plasma Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2015 – 2026

3.3. Industry ecosystem

3.3.1.  Value chain analysis

3.3.2.  Distribution channel analysis

3.4. Industry impact forces

3.4.1.  Growth drivers

3.4.1.1. Higher number of blood transfusions in Europe

3.4.1.2. Recent advances in therapeutic protein drug development

3.4.1.3. Increasing prevalence of liver diseases in elderly population

3.4.1.4. Exclusive use of plasma for treatment of rare diseases in Europe

3.4.1.5. Fair reimbursement in developed countries

3.4.2.  Industry pitfalls & challenges

3.4.2.1. Stringent regulatory policies

3.4.2.2. Affordability issue in APAC and Latin America due to high costs

3.5. Growth potential analysis

3.5.1.  By component

3.5.2.  By application

3.5.3.  By distribution channel

3.6. COVID-19 impact analysis

3.7. Porter’s analysis

3.8. PESTEL analysis

Chapter 4.  Platelet and Plasma Market, By Component

4.1. Key segment trends

4.2. Platelets

4.2.1.  Market size, by region, 2015 – 2026 (USD Million)

4.3. Plasma

4.3.1.  Market size, by region, 2015 – 2026 (USD Million)

Chapter 5.  Platelet and plasma Market, By Application

5.1. Key segment trends

5.2. Hemophilia

5.2.1.  Market size, by region, 2015-2026 (USD Million)

5.3. Thrombocytopenia

5.3.1.  Market size, by region, 2015-2026 (USD Million)

5.4. Perioperative indications

5.4.1.  Market size, by region, 2015-2026 (USD Million)

5.5. Platelet function disorders

5.5.1.  Market size, by region, 2015-2026 (USD Million)

5.6. Other platelet applications

5.6.1.  Market size, by region, 2015-2026 (USD Million)

5.7. Coagulation factor deficiencies

5.7.1.  Market size, by region, 2015-2026 (USD Million)

5.8. Thrombotic thrombocytopenic purpura

5.8.1.  Market size, by region, 2015-2026 (USD Million)

5.9. Hemorrhage

5.9.1.  Market size, by region, 2015-2026 (USD Million)

5.10.  Liver disease

5.10.1.   Market size, by region, 2015-2026 (USD Million)

5.11.  Other plasma applications

5.11.1.   Market size, by region, 2015-2026 (USD Million)

Chapter 6.  Platelet and Plasma Market, By Distribution Channel

6.1. Key segment trends

6.2. Hospitals

6.2.1.  Market size, by region, 2015 – 2026 (USD Million)

6.3. Ambulatory surgical centers

6.3.1.  Market size, by region, 2015 – 2026 (USD Million)

6.4. Others

6.4.1.  Market size, by region, 2015 – 2026 (USD Million)

Chapter 7.  Platelet and plasma Market, By Region

7.1. Platelet and plasma market share, by region, 2017 & 2024

7.2. North America

7.2.1.  Market size, by country, 2015 – 2026 (USD Million)

7.2.2.  Market size, by component, 2015 – 2026 (USD Million)

7.2.3.  Market size, by application, 2015 – 2026 (USD Million)

7.2.4.  Market size, by distribution channel, 2015 – 2026 (USD Million)

7.2.5.  U.S.

7.2.5.1.  Market size, by component, 2015 – 2026 (USD Million)

7.2.5.2.    Market size, by application, 2015 – 2026 (USD Million)

7.2.5.3.    Market size, by distribution channel, 2015 – 2026 (USD Million)

7.2.6.  Canada

7.2.6.1.  Market size, by component, 2015 – 2026 (USD Million)

7.2.6.2.    Market size, by application, 2015 – 2026 (USD Million)

7.2.6.3.    Market size, by distribution channel, 2015 – 2026 (USD Million)

7.3. Europe

7.3.1.  Market size, by country, 2015 – 2026 (USD Million)

7.3.2.  Market size, by component, 2015 – 2026 (USD Million)

7.3.3.  Market size, by application, 2015 – 2026 (USD Million)

7.3.4.  Market size, by distribution channel, 2015 – 2026 (USD Million)

7.3.5. Germany

7.3.5.1.  Market size, by component, 2015 – 2026 (USD Million)

7.3.5.2.    Market size, by application, 2015 – 2026 (USD Million)

7.3.5.3.    Market size, by distribution channel, 2015 – 2026 (USD Million)

7.3.6. UK

7.3.6.1.  Market size, by component, 2015 – 2026 (USD Million)

7.3.6.2.    Market size, by application, 2015 – 2026 (USD Million)

7.3.6.3.    Market size, by distribution channel, 2015 – 2026 (USD Million)

7.3.7. France

7.3.7.1.  Market size, by component, 2015 – 2026 (USD Million)

7.3.7.2.    Market size, by application, 2015 – 2026 (USD Million)

7.3.7.3.    Market size, by distribution channel, 2015 – 2026 (USD Million)

7.3.8. Italy

7.3.8.1.  Market size, by component, 2015 – 2026 (USD Million)

7.3.8.2.    Market size, by application, 2015 – 2026 (USD Million)

7.3.8.3.    Market size, by distribution channel, 2015 – 2026 (USD Million)

7.3.9. Spain

7.3.9.1.  Market size, by component, 2015 – 2026 (USD Million)

7.3.9.2.    Market size, by application, 2015 – 2026 (USD Million)

7.3.9.3.    Market size, by distribution channel, 2015 – 2026 (USD Million)

7.4. Asia Pacific

7.4.1. Market size, by country, 2015 – 2026 (USD Million)

7.4.2.  Market size, by component, 2015 – 2026 (USD Million)

7.4.3.  Market size, by application, 2015 – 2026 (USD Million)

7.4.4.  Market size, by distribution channel, 2015 – 2026 (USD Million)

7.4.5. Japan

7.4.5.1. Market size, by component, 2015 – 2026 (USD Million)

7.4.5.2. Market size, by application, 2015 – 2026 (USD Million)

7.4.5.3.  Market size, by distribution channel, 2015 – 2026 (USD Million)

7.4.6. China

7.4.6.1.  Market size, by component, 2015 – 2026 (USD Million)

7.4.6.2.    Market size, by application, 2015 – 2026 (USD Million)

7.4.6.3.    Market size, by distribution channel, 2015 – 2026 (USD Million)

7.4.7. India

7.4.7.1.  Market size, by component, 2015 – 2026 (USD Million)

7.4.7.2.    Market size, by application, 2015 – 2026 (USD Million)

7.4.7.3.    Market size, by distribution channel, 2015 – 2026 (USD Million)

7.5. Latin America

7.5.1.  Market size, by country, 2015 – 2026 (USD Million)

7.5.2.  Market size, by component, 2015 – 2026 (USD Million)

7.5.3.  Market size, by application, 2015 – 2026 (USD Million)

7.5.4.  Market size, by distribution channel, 2015 – 2026 (USD Million)

7.5.5. Brazil

7.5.5.1.  Market size, by component, 2015 – 2026 (USD Million)

7.5.5.2.    Market size, by application, 2015 – 2026 (USD Million)

7.5.5.3.    Market size, by distribution channel, 2015 – 2026 (USD Million)

7.5.6. Mexico

7.5.6.1.  Market size, by component, 2015 – 2026 (USD Million)

7.5.6.2.    Market size, by application, 2015 – 2026 (USD Million)

7.5.6.3.    Market size, by distribution channel, 2015 – 2026 (USD Million)

7.6. Middle East and Africa

7.6.1.  Market size, by country, 2015 – 2026 (USD Million)

7.6.2.  Market size, by component, 2015 – 2026 (USD Million)

7.6.3.  Market size, by application, 2015 – 2026 (USD Million)

7.6.4.  Market size, by distribution channel, 2015 – 2026 (USD Million)

7.6.5. South Africa

7.6.5.1.  Market size, by component, 2015 – 2026 (USD Million)

7.6.5.2.    Market size, by application, 2015 – 2026 (USD Million)

7.6.5.3.    Market size, by distribution channel, 2015 – 2026 (USD Million)

7.6.6. Saudi Arabia

7.6.6.1.  Market size, by component, 2015 – 2026 (USD Million)

7.6.6.2.    Market size, by application, 2015 – 2026 (USD Million)

7.6.6.3.    Market size, by distribution channel, 2015 – 2026 (USD Million)

Chapter 8.  Company Profiles     

8.1. Strategy Dashboard

8.2. America’s Blood Centers

8.2.1.  Business overview

8.2.2.  Financial data

8.2.3.  Product landscape

8.2.4.  Strategic outlook

8.2.5.  SWOT analysis

8.3. American Red Cross

8.3.1.  Business overview

8.3.2.  Financial data

8.3.3.  Product landscape

8.3.4.  Strategic outlook

8.3.5.  SWOT analysis

8.4. American Association of Blood Banks

8.4.1.  Business overview

8.4.2.  Financial data

8.4.3.  Product landscape

8.4.4.  Strategic outlook

8.4.5.  SWOT analysis

8.5. Blood Centers of America

8.5.1.  Business overview

8.5.2.  Financial data

8.5.3.  Product landscape

8.5.4.  Strategic outlook

8.5.5.  SWOT analysis

8.6. European Blood Alliance

8.6.1.  Business overview

8.6.2.  Financial data

8.6.3.  Product landscape

8.6.4.  Strategic outlook

8.6.5.  SWOT analysis

8.7. Indian Red Cross

8.7.1.  Business overview

8.7.2.  Financial data

8.7.3.  Product landscape

8.7.4.  Strategic outlook

8.7.5.  SWOT analysis

8.8. Italian Red Cross

8.8.1.  Business overview

8.8.2.  Financial data

8.8.3.  Product landscape

8.8.4.  Strategic outlook

8.8.5.  SWOT analysis

8.9. Japanese Red Cross

8.9.1.  Business overview

8.9.2.  Financial data

8.9.3.  Product landscape

8.9.4.  Strategic outlook

8.9.5.  SWOT analysis

8.10.  South African Red Cross Society

8.10.1.   Business overview

8.10.2.    Financial data

8.10.3.    Product landscape

8.10.4.    Strategic outlook

8.10.5.    SWOT analysis

8.11.  OneBlood

8.11.1.   Business overview

8.11.2.    Financial data

8.11.3.    Product landscape

8.11.4.    Strategic outlook

8.11.5.    SWOT analysis

Don't see your key competitors?

The companies listed in this report are a curated selection - not the full competitive universe.

Our market revenue calculations use a bottom-up methodology that accounts for all players across all regions - including manufacturers, distributors, and specialists not individually profiled. The profiles section spotlights strategically significant players; it does not define the scope of our market sizing.

Your competitive landscape may also include

Regional or domestic-only leaders not in the global top tier
Distributors and channel partners who control market access
Emerging disruptors, startups, or adjacent-industry entrants
Niche players focused on a specific application or end-use

Free customization - up to 20% of report value

Need specific data? Request customization and get the insights tailored to your exact requirements.

Authors: Monali Tayade, Jignesh Rawal

For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at [email protected]

Explore our licensing options:

Starting at: $2,450

Premium Report Details

Base Year: 2019

Companies Profiled: 10

Tables and Figures: 91

Countries covered: 14

Pages: 110

Download Free PDF

img

Platelet and Plasma Market

Get a free sample of this report
country Flag
+1
img
Get a free sample of this report Platelet and Plasma Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Your personal details will remain secure and confidential

Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!